CLINICAL_TRIALS
trial_result
· 2016-02-05
Clinical Trial Update: Januvia Re-examination Study (MK-0431-181)
Summary
The Januvia re-examination study MK-0431-181 for type 2 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED